Glenda Margaret Halliday

Alzheimer s Research & Therapy · 2014

⊕ Open access · CC-BY

Alpha-synuclein biology in Lewy body diseases

▲ 375

PubMed · 2001

◌ Preprint

Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.

▲ 343

Annals of the New York Academy of Sciences · 2009

◌ Citation only

The progression of pathology in Parkinson's disease

▲ 300

Acta Neuropathologica · 2016

⊕ Open access · CC-BY

Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology

▲ 273

Brain · 2005

⊕ Open access · OA

α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease

▲ 220

Human Molecular Genetics · 2014

⊕ Open access · OA

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

▲ 219

npj Parkinson s Disease · 2021

⊕ Open access · CC-BY

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

▲ 168

Frontiers in Cell and Developmental Biology · 2021

⊕ Open access · CC-BY

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease

▲ 93

Journal of Parkinson s Disease · 2021

⊕ Open access · CC-BY

Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients

▲ 37

Neuroscience · 2018

⊕ Open access · CC-BY

Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration

▲ 36

Movement Disorders · 2024

⊕ Open access · CC-BY

Research Priorities on the Role of α‐ Synuclein in Parkinson's Disease Pathogenesis

▲ 29

bioRxiv (Cold Spring Harbor Laboratory) · 2026

⊕ Preprint · CC-BY

Alpha-synuclein and neuromelanin converge to promote Parkinsons disease pathology

▲ 0